Emilia Hadziyannis Selected Research

ethyl 4-chloro-3-hydroxybutanoate (CHBE)

1/2022

Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emilia Hadziyannis Research Topics

Disease

18	Chronic Hepatitis B 11/2022 - 01/2008
8	Infections 12/2021 - 07/2008
7	Rheumatic Diseases (Rheumatism) 12/2021 - 07/2008
7	Chronic Hepatitis C 11/2018 - 03/2007
7	Fibrosis (Cirrhosis) 11/2018 - 01/2008
6	Hepatitis B 11/2022 - 01/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2013
4	Tuberculosis (Tuberculoses) 01/2020 - 07/2008
3	Non-alcoholic Fatty Liver Disease 01/2017 - 10/2009
2	Peritonitis 12/2021 - 11/2021
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 11/2020
2	Liver Diseases (Liver Disease) 04/2020 - 01/2008
2	Pericarditis 01/2020 - 04/2014
2	Cryoglobulinemia 11/2018 - 05/2013
2	Fatty Liver 01/2017 - 04/2010
2	Alcoholic Fatty Liver 01/2017 - 01/2008
2	Latent Tuberculosis 07/2008 - 07/2008
1	End Stage Liver Disease 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2020
1	Viremia 04/2020
1	Neoplasms (Cancer) 01/2020
1	Rheumatoid Arthritis 01/2017
1	Inflammation (Inflammations) 01/2017
1	Osteoarthritis 01/2017
1	Psoriatic Arthritis 01/2017
1	Necrosis 10/2015
1	Persistent Infection 01/2013
1	Hepatitis C 01/2013
1	Insulin Resistance 10/2009
1	Hepatitis 01/2008
1	Crohn Disease (Crohn's Disease) 06/2007
1	Spondylarthropathies 06/2007
1	Thrombotic Thrombocytopenic Purpura 03/2007

Drug/Important Bio-Agent (IBA)

16	Hepatitis B e AntigensIBA 11/2022 - 01/2008
10	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 09/2012
7	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2011
4	AntigensIBA 11/2022 - 11/2017
4	Tuberculin (PPD)IBA 01/2020 - 07/2008
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2013
3	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2013
3	Biological ProductsIBA 12/2021 - 01/2020
3	InterferonsIBA 01/2020 - 03/2007
3	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 07/2008
3	entecavir FDA Link 01/2018 - 01/2013
3	Tenofovir (Viread)FDA Link 01/2018 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 07/2008
3	EnzymesIBA 07/2008 - 02/2008
2	nasIBA 04/2020 - 01/2019
2	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 07/2008
2	lipopolysaccharide-binding proteinIBA 01/2017 - 01/2017
2	Keratin-18 (Keratin 18)IBA 01/2011 - 04/2010
2	AdipokinesIBA 10/2009 - 01/2008
1	ethyl 4-chloro-3-hydroxybutanoate (CHBE)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2021
1	Bacterial DNAIBA 11/2021
1	CreatinineIBA 11/2020
1	Complement System Proteins (Complement)IBA 11/2020
1	MucinsIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Colchicine FDA LinkGeneric 01/2020
1	GlucocorticoidsIBA 01/2020
1	Vitamin D FDA LinkGeneric 11/2018
1	B-Cell Activating FactorIBA 11/2018
1	Interleukin-17 (Interleukin 17)IBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 09/2018
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	CytokinesIBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Ribavirin (Virazole)FDA LinkGeneric 01/2016
1	Interleukin-8 (Interleukin 8)IBA 04/2014
1	CryoglobulinsIBA 05/2013
1	Fetal Proteins (Fetoprotein)IBA 02/2013
1	Rituximab (Mabthera)FDA Link 02/2013
1	adefovirIBA 09/2012
1	CaspasesIBA 04/2010
1	Vitamin A (Retinol)FDA LinkGeneric 10/2009
1	Insulin (Novolin)FDA Link 10/2009
1	ImmunosorbentsIBA 07/2008
1	Immunoglobulin M (IgM)IBA 02/2008
1	ResistinIBA 01/2008
1	LeptinIBA 01/2008
1	AdiponectinIBA 01/2008
1	Infliximab (Remicade)FDA Link 06/2007

Therapy/Procedure

12	Therapeutics 11/2022 - 01/2011
3	Aftercare (After-Treatment) 01/2022 - 09/2018
2	Retreatment 01/2020 - 01/2018
1	Renal Dialysis (Hemodialysis) 11/2020
1	Immunotherapy 01/2020
1	Duration of Therapy 01/2019